Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States
Dr. Brunner is a Professor of Pediatrics at the University of Cincinnati. She directs the Division of Rheumatology at Cincinnati Children's Hospital. As Scientific Director of the PRCSG she is designing and conducting clinical trials. Her personal research is in kidney and brain biomarkers for use in children with lupus.
Diagnostic and Prognostic Biomarkers
Sunday, November 12, 2023
9:15 AM – 9:30 AM PT
Disclosure(s): AbbVie: Consultant (Ongoing); AstraZeneca-Medimmune: Consultant (Ongoing); Biogen: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb (BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Celgene: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); EMD Serono: Consultant (Ongoing); F-Hoffman La Roche: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein (GSK): Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon: Consultant (Ongoing), Consultant (Ongoing); Janssen: Grant/Research Support (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): AbbVie: Consultant (Ongoing); AstraZeneca-Medimmune: Consultant (Ongoing); Biogen: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb (BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Celgene: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); EMD Serono: Consultant (Ongoing); F-Hoffman La Roche: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein (GSK): Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon: Consultant (Ongoing), Consultant (Ongoing); Janssen: Grant/Research Support (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Monday, November 13, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): AbbVie: Consultant (Ongoing); AstraZeneca-Medimmune: Consultant (Ongoing); Biogen: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb (BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Celgene: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing), Grant/Research Support (Ongoing); EMD Serono: Consultant (Ongoing); F-Hoffman La Roche: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein (GSK): Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon: Consultant (Ongoing), Consultant (Ongoing); Janssen: Grant/Research Support (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)